M.v.i. and Megestrol acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take M.v.i. and Megestrol acetate together.

The phase IV clinical study analyzes what interactions people who take M.v.i. and Megestrol acetate have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

4 people who take M.v.i. and Megestrol acetate together, and have interactions are studied.


What is M.v.i.?

M.v.i. has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. eHealthMe is studying from 2,493 M.v.i. users for its effectiveness, alternative drugs and more.

What is Megestrol acetate?

Megestrol acetate has active ingredients of megestrol acetate. It is often used in appetite - decreased. eHealthMe is studying from 4,833 Megestrol acetate users for its effectiveness, alternative drugs and more.

Number of M.v.i. and Megestrol acetate reports submitted per year:

M.v.i. and Megestrol acetate drug interactions.

Common M.V.I. and Megestrol Acetate drug interactions by gender *:

female:

n/a

male:

  1. Weakness
  2. Akinesia
  3. Diarrhoea
  4. Difficulty in walking
  5. Disorientation
  6. Dry mouth
  7. Dysarthria
  8. Dyspnoea
  9. Fall
  10. Femur fracture

Common M.V.I. and Megestrol Acetate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Weakness
  2. Akinesia
  3. Difficulty in walking
  4. Disorientation
  5. Dry mouth
  6. Dysarthria
  7. Dyspnoea
  8. Fall
  9. Femur fracture
  10. Foreign body trauma

* Approximation only. Some reports may have incomplete information.

Do you take M.v.i. and Megestrol acetate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of M.v.i. and Megestrol acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common M.v.i. side effects:

Browse all side effects of M.v.i.:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Megestrol acetate side effects:

Browse all side effects of Megestrol acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common M.v.i. interactions:

Browse all interactions between M.v.i. and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Megestrol acetate interactions:

Browse all interactions between Megestrol acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e and megestrol acetate (the active ingredients of M.v.i. and Megestrol acetate, respectively), and M.v.i. and Megestrol acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides M.v.i. and Megestrol acetate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: